Physician

Ahmed F Okba, MD

According to 2025 Medicare claims, Ahmed Okba, MD (NPI: 1538139100) practices internal medicine in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is MEDICAL ARTS ASSOCIATES, LTD. (NPI: 1396724183; TIN: 362689597) and primary practice location at 61265-6812. Okba is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Okba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 444 traditional Medicare patients, billed 6,897 HCPCS/CPT codes, and received $175,373 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14,030 prescription claims across 942 beneficiaries totaling $1,079,256 in drug costs, led by Eliquis (Apixaban). DME data shows 588 claims. Open Payments data shows 32 records totaling $724. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $790,299 to $1,079,256. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $35,572 to $43,642.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	698	10,943	$242,116
2016	553	8,690	$203,616
2017	575	9,064	$211,346
2018	538	9,674	$219,403
2019	520	8,571	$201,854
2020	505	7,714	$191,366
2021	483	7,168	$191,586
2022	472	7,704	$196,609
2023	437	7,351	$192,076
2024	444	6,897	$175,373

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	641	12,939	$790,299
2016	665	12,725	$786,783
2017	703	12,113	$749,977
2018	696	12,064	$819,000
2019	736	12,478	$853,125
2020	770	13,406	$933,086
2021	799	13,137	$924,908
2022	836	13,551	$1,012,261
2023	843	13,895	$1,209,786
2024	942	14,030	$1,079,256

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	154	625	$29,992
2016	120	507	$13,638
2017	120	558	$11,728
2018	162	500	$10,820
2019	147	413	$9,066
2020	124	318	$9,328
2021	115	349	$12,797
2022	95	402	$17,248
2023	150	492	$27,880
2024	175	588	$41,076

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	565	$80
80061	Blood test, lipids (cholesterol and triglycerides)	323	660	$13
80053	Blood test, comprehensive group of blood chemicals	338	754	$10
36415	Insertion of needle into vein for collection of blood sample	349	846	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	298	409	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	159	8,513	$165,441
Ozempic	Semaglutide	95	4,240	$140,899
Jardiance	Empagliflozin	68	4,295	$80,388
Januvia	Sitagliptin Phosphate	82	4,076	$75,101
Mounjaro	Tirzepatide	56	1,736	$64,787

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	12	58	$24,593
E0601	Continuous positive airway pressure (cpap) device	Y	15	105	$2,964
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	29	$2,135
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	12	25	$1,742
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	18	35	$1,676

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$724	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed F. Okba, MD?

Tedicare shows public-source Medicare data for Ahmed F. Okba, MD (NPI 1538139100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed F. Okba, MD have ACO affiliation data?

Ahmed F. Okba, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ahmed F. Okba, MD?

Ahmed F. Okba, MD is linked to MEDICAL ARTS ASSOCIATES, LTD. (billing NPI 1396724183) in the available physician profile data.

Does Ahmed F. Okba, MD have Open Payments data?

Ahmed F. Okba, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.